Jorge Iván Montoya Salazar Momtoya Salazar

Dr. Jorge Iván Montoya Salazar Momtoya Salazar

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 March 2026 in Pathogens
Verified
Journal Article
Open access
PDF file
AQAlejandra Mondragón Quiguanas
Alejandra Mondragón Quiguanas
JSJorge Iván Montoya Salazar Momtoya Salazar
Jorge Iván Montoya Salazar Momtoya Salazar
JMJuan Camilo Mosquera-Hernandez
Juan Camilo Mosquera-Hernandez
MAMargareth Zuluaga Aricapa
Margareth Zuluaga Aricapa
CFCarlos Eduardo Pinzón Flórez
Carlos Eduardo Pinzón Flórez
MRMarcela Díaz Rivadeneira
Marcela Díaz Rivadeneira
Background: Antimicrobial resistance is a threat that increases morbidity and mortality. This cross-sectional study aimed to describe the profile of priority antimicrobial-resistant pathogens and to analyze the behavior of multidrug-resistant tuberculosis (MDR-TB) in the Santiago de Cali District, Colombia. Methods: researchers compiled information from data provided by healthcare institutions, the National Public Health Surveillance System, and laboratory-based surveillance using the World Health Organization’s WHONET v.5.6 software. Univariate statistical analysis described trends in pathogen resistance, and multivariate analysis analyzed the behavior of MDR-TB. Results: Among Gram-negative bacteria, high levels of carbapenem resistance were observed in A. baumannii (84% aztreonam resistance) and in K. pneumoniae (63%). P. aeruginosa exhibited elevated multidrug resistance, consistent with extensive antimicrobial selective pressure. MDR-TB exhibited a high burden of resistance, reaching 96%, with projections indicating a potential increase driven by monoresistance and resistance to rifampicin. Patients with drug-resistant tuberculosis who were HIV-positive or experiencing homelessness had a significantly higher likelihood of hospitalization (OR 5.59; 95% CI 3.09–10.11 and OR 2.94; 95% CI 1.48–5.81, respectively) and mortality (OR 3.34; 95% CI 1.72–6.49 and OR 2.59; 95% CI 1.16–5.79, respectively). Conclusions: The expansion of resistance mechanisms suggests sustained selective pressure, underscoring the need for strategies to optimize antibiotics.

10 April 2025 in medRxiv
Verified
Preprint
Open access
PDF file
PRPablo Roa-Urrutia
Pablo Roa-Urrutia
ACAndres Felipe Valencia Cardona
Andres Felipe Valencia Cardona
CRCarlos Reina
Carlos Reina
GGGissel Guzmán-Escarria
Gissel Guzmán-Escarria
JSJorge Iván Montoya Salazar Momtoya Salazar
Jorge Iván Montoya Salazar Momtoya Salazar
ACAlberto Concha-Eastman
Alberto Concha-Eastman
Objectives To analyze the association between respiratory failure and sociodemographic determinants in patients hospitalized with Severe Acute Respiratory Infection (SARI) in Cali, Colombia, in 2022. Method A descriptive and cross-sectional study was conducted using data from the 2022 respiratory failure notification file No. 348. A generalized linear model with an exponential binomial family was applied. Absolute frequencies, proportions, and odds ratios (OR) were estimated. Results Of 1,163 patients, 4.5% (n=52) developed respiratory failure. Those with high [OR: 2.03; 95%CI: 1.2–2.8] or medium-high [OR: 1.4; 95%CI: 0.9–3.7] vulnerability had a greater likelihood of respiratory failure compared to patients with low vulnerability. Asthma and COPD increased the risk [OR: 4.3; 95%CI: 1.5–6.03] and [OR: 3.3; 95%CI: 1.3–4.3], respectively. Sepsis was also identified as a significant risk factor [OR: 2.7; 95%CI: 1.8–3.5]. Conclusions The results emphasize the need for targeted public health actions. Sociodemographic factors, especially multidimensional poverty such as limited education, income, and healthcare access play a key role in respiratory failure outcomes.